evidencegaps
Primary study · included by 1 review

CSChighE-cadherinlow immunohistochemistry panel predicts poor prognosis in oral squamous cell carcinoma

Ortiz 2024 · Ortiz Rafael Carneiro, Amôr Nádia Ghinelli, Saito Luciana Mieli, et al. · Scientific Reports · 2024

Included by

Computational Stemness and Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma: A Systematic Review, Dual Meta-Analysis, and Functional Meta-Synthesis.
Non-Cochrane · prognostic · 2025 · cited as Ortiz 2024 · Table 1; References
Outcome this study informsPooled effectEvidenceCertainty
Overall survival
CSC-positive immunophenotype by tissue immunohistochemistry (CD44, CD133, xCT/SLC7A11) vs CSC-negative or low immunophenotype
HR 2.01 [1.42, 2.84]2 studiesLow
Overall survival
CSC-positive immunophenotype by tissue immunohistochemistry (CD44, CD133, xCT/SLC7A11) vs CSC-negative or low immunophenotype
HR 0.77 [0.16, 3.81]3 studiesGRADE not reported

1 including review in total.